Corbus Pharmaceuticals
CRBP
#10362
Rank
NZ$77.59 M
Marketcap
NZ$3.77
Share price
-15.40%
Change (1 day)
-82.39%
Change (1 year)

EPS for Corbus Pharmaceuticals (CRBP)

EPS in 2026 (TTM): NZ-$10.76

According to Corbus Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$11.32. In 2025 the company made an earnings per share (EPS) of NZ-$10.93 a decrease over its 2024 EPS that were of NZ-$6.69.

EPS history for Corbus Pharmaceuticals from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$10.76-1.54%
2025NZ-$10.9363.39%
2024NZ-$6.69
2022NZ-$18.57-13.16%
2021NZ-$21.39-73.65%
2020NZ-$81.1630.97%
2019NZ-$61.9715.31%
2018NZ-$53.74

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Viking Therapeutics
VKTX
NZ-$9.87-12.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
NZ-$8.45-25.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS.defunct
NZ-$17.71 56.54%๐Ÿ‡บ๐Ÿ‡ธ USA